The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer

Source of Estrogen Production in Postmenopausal Women1

Jerrold Grodin, Pentti K. Siiteri, Paul C. MacDonald · The Journal of Clinical Endocrinology & Metabolism · 1973 · 963 citations

Life Sciences, Endocrinology, Physiology +16

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

Richard J. Santen, Steven J. Santner, BONNIE DAVIS et al. · The Journal of Clinical Endocrinology & Metabolism · 1978 · 341 citations

Life Sciences, Endocrinology, Pharmacology +17

Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route.

Mitch Dowsett, Paul E. Goss, TJ Powles et al. · PubMed · 1987 · 240 citations

Medicine, Oncology, Pharmacology +17

Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.

P. A. Goss, TJ Powles, Mitch Dowsett et al. · PubMed · 1986 · 216 citations

Medicine, Oncology, Pharmacology +13

Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients.

Mitch Dowsett, David Cunningham, Robert C. Stein et al. · PubMed · 1989 · 141 citations

Pharmacy, Pharmacokinetics, Pharmacology +17